Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 10, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2033

Conditions
Ovarian Cancer
Interventions
PROCEDURE

Secondary Cytoreductive Surgery

"Surgery will only be performed in patients assigned to the experimental arm of the study.~The goal of secondary cytoreductive surgery is to achieve complete tumor reduction by removing all visible residual tumors (Complete cytoreduction with no macroscopic residual disease), and this effort should be the top priority."

Trial Locations (1)

10408

RECRUITING

National Cancer Center, Korea, Goyang-si

All Listed Sponsors
lead

National Cancer Center, Korea

OTHER_GOV

NCT07171528 - Secondary Cytoreductive Surgery After Chemotherapy for Recurrent Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter